155 related articles for article (PubMed ID: 24731197)
1. Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000-2009.
Hu Y; Zhao Q; Rao J; Deng H; Yuan H; Xu B
BMC Public Health; 2014 Apr; 14():356. PubMed ID: 24731197
[TBL] [Abstract][Full Text] [Related]
2. Incidence, mortality and five-year relative survival ratio of prostate cancer among Chinese residents in Singapore from 1968 to 2002 by metastatic staging.
Chia SE; Tan CS; Lim GH; Sim X; Lau W; Chia KS
Ann Acad Med Singap; 2010 Jun; 39(6):466-71. PubMed ID: 20625623
[TBL] [Abstract][Full Text] [Related]
3. Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009.
Qi D; Wu C; Liu F; Gu K; Shi Z; Lin X; Tao S; Xu W; Brendler CB; Zheng Y; Xu J
Prostate; 2015 Oct; 75(14):1662-8. PubMed ID: 26184773
[TBL] [Abstract][Full Text] [Related]
4. Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.
Harris AM; Warner BW; Wilson JM; Becker A; Rowland RG; Conner W; Lane M; Kimbler K; Durbin EB; Baron AT; Kyprianou N
J Urol; 2007 Nov; 178(5):2176-80. PubMed ID: 17870114
[TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic determinants of prostate cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
Beksisa J; Getinet T; Tanie S; Diribi J; Hassen HY
PLoS One; 2020; 15(3):e0229854. PubMed ID: 32134996
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
7. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998.
Majeed A; Babb P; Jones J; Quinn M
BJU Int; 2000 Jun; 85(9):1058-62. PubMed ID: 10848694
[TBL] [Abstract][Full Text] [Related]
8. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China.
Liu X; Yu C; Bi Y; Zhang ZJ
Public Health; 2019 Jul; 172():70-80. PubMed ID: 31220754
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer incidence and mortality trends among elderly and adult Europeans.
Vercelli M; Quaglia A; Marani E; Parodi S
Crit Rev Oncol Hematol; 2000 Aug; 35(2):133-44. PubMed ID: 10936470
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
11. A comparative population-based study of prostate cancer incidence and mortality rates in Singapore, Sweden and Geneva, Switzerland from 1973 to 2006.
Chen C; Naidoo N; Yang Q; Hartman M; Verkooijen HM; Loy EY; Bouchardy C; Chia KS; Chia SE
BMC Cancer; 2012 Jun; 12():222. PubMed ID: 22673095
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer trends in Canada: rising incidence or increased detection?
Levy IG; Gibbons L; Collins JP; Perkins DG; Mao Y
CMAJ; 1993 Sep; 149(5):617-24. PubMed ID: 8364818
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China.
Lacey JV; Deng J; Dosemeci M; Gao YT; Mostofi FK; Sesterhenn IA; Xie T; Hsing AW
Int J Epidemiol; 2001 Apr; 30(2):341-9. PubMed ID: 11369740
[TBL] [Abstract][Full Text] [Related]
14. [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008].
Peng P; Gong YM; Bao PP; Ke JZ; Xiang YM; Zhang ML; Zheng Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1056-9. PubMed ID: 23290851
[TBL] [Abstract][Full Text] [Related]
15. [Incidence and survival condition of primary liver cancer among residents in Pudong district of Shanghai, from 2002 to 2011].
Yang LM; Li XP; Yang C; Yan B; Zhang MY; Fu YF; Sun Q; Cao GW
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1016-20. PubMed ID: 23290842
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and temporal trend of suicide mortality in the elderly in Jiading, Shanghai, 2003-2013: a descriptive, observational study.
Shao Y; Zhu C; Zhang Y; Yu H; Peng H; Jin Y; Shi G; Wang N; Chen Z; Chen Y; Jiang Q
BMJ Open; 2016 Aug; 6(8):e012227. PubMed ID: 27543591
[TBL] [Abstract][Full Text] [Related]
17. [Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].
Liao ML; Chen ZW; Zheng Y; Wu CX; Lu S; Yu YF; Jian H; Cheng BJ
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1876-80. PubMed ID: 17923007
[TBL] [Abstract][Full Text] [Related]
18. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Mortality of Prostate Cancer in Canada during 1992-2010.
Lagacé F; Ghazawi FM; Le M; Savin E; Zubarev A; Powell M; Moreau L; Sasseville D; Popa I; Litvinov IV
Curr Oncol; 2021 Feb; 28(1):978-990. PubMed ID: 33617514
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014.
Innos K; Baburin A; Kotsar A; Eiche IE; Lang K
Scand J Urol; 2017 Dec; 51(6):442-449. PubMed ID: 29092653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
